Unity Biotechnology, Inc.
A clinical-stage biopharmaceutical company focused on developing therapeutics to slow, stop or reverse the progression of age-related diseases. The company is developing treatments that target senescent cells to treat eye diseases, including diabetic macular edema and age-related macular degeneration. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 19 |
Founded | 2009 |
Financials | |
|---|---|
Market Capitalization | 26.02M |
Revenue | |
Operating Income | -41.61M |
Operating Margin | |
Net Income | -34.78M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4353 / 5373 |
Sector : Healthcare | 674 / 1144 |
Industry : Biotechnology | 301 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4844 / 5565 |
Sector : Healthcare | 913 / 1182 |
Industry : Biotechnology | 510 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4129 / 5436 |
Sector : Healthcare | 618 / 1164 |
Industry : Biotechnology | 277 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4827 / 5330 |
Sector : Healthcare | 967 / 1174 |
Industry : Biotechnology | 498 / 667 |